Loading organizations...
§ Venture Capital · Boston, MA, USA
Life sciences research and investment firm focused on genomics and synthetic biology, investing in early-stage biotech companies.
"Biotechonomy" does not appear to be a specific company, but rather a term that refers to the economic aspects and activities within the biotechnology sector. Web searches for "Biotechonomy company" or related terms yield results discussing the biotechnology industry broadly, directories of biotech companies, or comparisons between biotech and pharmaceutical firms, rather than identifying a singular corporate entity named "Biotechonomy."
The term itself combines "bio" (life) and "economy," suggesting a focus on how biological processes and resources are leveraged for economic value, innovation, and industry growth. This encompasses a wide array of activities from biopharmaceutical development and agricultural biotechnology to industrial biotech and bio-manufacturing. It represents the collective commercial landscape driven by biological research and technological advancements.
Given that "Biotechonomy" functions as an umbrella term for a vast and diverse industry, it does not have founders, a singular core product, or a unified mission in the way a single company would. The concept describes the intricate ecosystem of companies, research institutions, and financial flows that together constitute the global biotechnology market.
Biotechonomy has 1 tracked investment across 1 company. The latest tracked deal is $6.5M Series A in New Matter in February 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 11, 2015 | New Matter | $6.5M Series A | Gilman Louie | Arden Road Investments, Dolby Family Ventures, First Round Capital, Frogventures, Idealab |